Summary
Milo Grotell is an M.D.-Ph.D. physician-scientist, founder and CEO with 11 years of clinical and research experience who now directs strategic governance and capital allocation for a healthcare-focused group in Helsinki. He has grown a 1.2 M€ portfolio while preserving >95% solvency and delivering a 45.4% total return on invested equity through disciplined risk management and structural reorganizations such as hive-downs. Board-experienced across both commercial and non-profit healthcare organisations, he combines regulatory fluency with clinical quality oversight to steer technology-enabled transformations. Milo blends hands-on clinical work and academic research with practical investment and operational leadership, advising on digital transformation, machine-learning applications, and compliance. Unusually for a clinician, he also manages multi-asset allocations including global ETFs and venture investments, applying fiduciary rigor to innovation. He is actively seeking board and advisory roles where scientific insight, data-driven strategy, and capital stewardship intersect.
10 years of coding experience
Matriculation Examination, Matriculation Examination at Lauttasaaren yhteiskoulu
Doctor of Medicine and Surgery — Ph.D., Doctor of Medicine and Surgery — Ph.D. at University of Helsinki
English, Finnish